Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| May 10, 2026 | UMR (UnitedHealthcare) | Pharmacogenetic Panel Testing | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Percutaneous Vertebroplasty and Kyphoplasty | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Percutaneous Patent Foramen Ovale (PFO) Closure | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Percutaneous Neuroablation for Pancreatic Cancer Pain, Severe Cancer Pain, and Trigeminal Neuralgia | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Parsabiv (Etelcalcetide) | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Papzimeos (Zopapogene Imadenovec-Drba) | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Panniculectomy Surgery | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Oxlumo (Lumasiran) and Rivfloza (Nedosiran) | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Outpatient Surgical Procedures – Site of Service | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Orthognathic (Jaw) Surgery | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Orencia (Abatacept) Injection for Intravenous Infusion | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Ophthalmologic Vascular Endothelial Growth Factor (VEGF) Inhibitors | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Ophthalmologic Complement Inhibitors | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Oncology Medication Clinical Coverage | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Omvoh (Mirikizumab-Mrkz) | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Omnibus Codes | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Office-Based Procedures – Site of Service | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Off-Label/Unproven Specialty Drug Treatment | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Ocular Photoscreening | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Ocrevus (Ocrelizumab) and Ocrevus Zunovo (Ocrelizumab and Hyaluronidase-Ocsq) | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Occipital Nerve Injections and Ablation (Including Occipital Neuralgia and Headache) | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Obstructive and Central Sleep Apnea Treatment | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Noncontact Warming Therapy, Ultrasound Therapy, and Fluorescence Imaging for Wounds | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Niktimvo (Axatilimab-Csfr) | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Neurophysiologic Testing and Monitoring | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Nerve Graft to Restore Erectile Function During Radical Prostatectomy | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Negative Pressure Wound Therapy | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Natalizumab (Tyruko & Tysabri) | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Motorized Spinal Traction | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Molecular Oncology Testing for Solid Tumor Cancer Diagnosis, Prognosis, and Treatment Decisions | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Molecular Oncology Testing for Hematologic Cancer Diagnosis, Prognosis, and Treatment Decisions | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Minimally Invasive Spine Surgery Procedures | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Minimally Invasive Procedures for the Treatment of Upper Gastrointestinal Diseases | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Medical Therapies for Enzyme Deficiencies | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Medical Benefit Therapeutic Equivalent Medications – Excluded Drugs | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Mechanical Stretching Devices | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Maximum Dosage and Frequency | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Manipulative Therapy | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Manipulation Under Anesthesia | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) Scan – Site of Service | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Luxturna (Voretigene Neparvovec-Rzyl) | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Lower Extremity Prosthetics | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Lower Extremity Endovascular Procedures | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Long-Acting Injectable Antiretroviral Agents for HIV | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Liposuction for Lipedema | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Light and Laser Therapy | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Leqvio (Inclisiran) | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Leqembi (Lecanemab-Irmb) | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Lemtrada (Alemtuzumab) | Criteria changed |
| May 10, 2026 | UMR (UnitedHealthcare) | Krystexxa (Pegloticase) | Criteria changed |